How can we support our cells as we age, beyond just taking vitamins and hoping for the best? EB Supplements’ Cellular Health Program offers an innovative two‑phase approach to proactive healthy aging, rooted in emerging research on cellular senescence, inflammaging, autophagy, and omega‑3 biology. This guide provides a science‑forward yet accessible overview of the program, its rationale, and how it can fit into a modern healthy aging routine.
The Science of Healthy Aging: Cells at the Centre
Healthy aging is increasingly understood as a cellular process. As the years pass, biological changes accumulate at the cellular level, influencing tissue function, resilience, and long‑term vitality¹².
Cellular Senescence, SASP, and Inflammaging
As we age, some cells enter a state known as cellular senescence: they stop dividing and functioning normally, but resist clearance³. These cells secrete a mix of inflammatory signals collectively referred to as the **senescence‑associated secretory phenotype (SASP)**⁴. Over time, the accumulation of senescent cells and their SASP is believed to contribute to chronic low‑grade inflammation, often described as inflammaging¹². This inflammatory environment may negatively affect neighbouring healthy cells and tissue function⁴⁵.
Senolytics: An Emerging Area of Research
Senolytics are compounds under investigation for their ability to selectively target senescent cells⁶. Among natural molecules, plant‑derived polyphenols such as fisetin, quercetin, and epigallocatechin gallate (EGCG) have attracted significant research interest⁵⁷.
In preclinical and ex‑vivo models, these compounds have demonstrated senolytic activity, forming the scientific basis for further exploration⁵⁷.
Research context: In an ex‑vivo study using human peripheral blood mononuclear cells (PBMCs), Dr. Samuel Fortin observed that a blend of fisetin, quercetin, and EGCG reduced the proportion of senescent cells under controlled laboratory conditions¹². These findings are exploratory and do not constitute clinical outcomes.
Autophagy: Cellular Renewal and Maintenance
Beyond senescence, healthy aging also depends on autophagy, the cell’s intrinsic recycling and renewal system⁸. Autophagy helps remove damaged proteins and organelles, supporting cellular homeostasis. Research indicates that autophagic efficiency declines with age⁹, making it a central focus of longevity science⁸⁹.
NAD⁺ and Cellular Energy
NAD⁺ is a critical coenzyme involved in cellular energy metabolism and repair pathways. NAD⁺ levels naturally decline with age and metabolic stress¹⁰. Nutritional strategies that support NAD⁺ availability, including the use of precursors such as NMN, are actively being studied for their role in maintaining cellular energy and metabolic resilience¹⁰¹¹.
Omega‑3 Fatty Acids and Cell Membrane Health
Cell membranes rely on adequate levels of omega‑3 fatty acids (EPA and DHA) for structure and signalling. Omega‑3 status is commonly assessed using the Omega‑3 Index, which reflects long‑term EPA and DHA incorporation into red blood cell membranes¹⁶.
Many individuals fail to reach the proposed target range of ~8%, partly due to limitations in omega‑3 absorption¹⁶. Advances in delivery formats, such as monoglyceride omega‑3s, aim to improve bioavailability and cellular uptake¹⁷.
The Two‑Phase Cellular Health Program
Drawing on these scientific concepts, EB Supplements developed a two‑phase, sequential Cellular Health Program designed to address different aspects of cellular aging.
Phase I — Reset: Senescence‑Focused Support
The first phase is a short‑term senescence‑targeting reset, inspired by senolytic research.
Fisétine+ Complexe Santé Cellulaire combines fisetin, quercetin, and EGCG—three polyphenols extensively studied in the context of senescence and oxidative stress⁵⁷. The formulation is positioned as a source of antioxidants that help protect cells against oxidative damage.
Research context:
• In an ex‑vivo PBMC model, a senolytic blend reduced senescence markers¹².
• In an exploratory single‑participant case study, a short‑term senolytic intervention was associated with a reduction in measured senescent PBMCs¹⁴.
These observations are preliminary and intended to inform research‑driven program design, not clinical claims.
Phase II — Protect & Maintain: Cellular Nourishment
The second phase focuses on longer‑term cellular protection and maintenance.
Entretien Cellulaire (Cell Maintenance) provides NMN alongside polyphenols such as resveratrol, luteolin, and pterostilbene, ingredients studied for their roles in NAD⁺ metabolism, cellular stress responses, and autophagy pathways¹⁰¹¹.
MAG‑O3® Omega‑3 formulations deliver EPA and DHA in a monoglyceride form designed to optimise absorption and support omega‑3 status, cell membrane health, and overall physiological balance¹⁶¹⁷.
Why the Phases Are Sequential
The two phases are intentionally non‑concomitant.
Research context: In a second ex‑vivo study, Dr. Fortin observed that combining a senolytic blend with omega‑3 supplementation altered senescence markers compared to using the senolytic blend alone¹³. This finding informed the decision to separate senolytic‑focused and omega‑3‑focused phases.
Additional exploratory case data suggest that optimising omega‑3 status before a senolytic phase may influence outcomes¹⁵, reinforcing the rationale for a structured, sequential approach.
A Science‑Informed Framework for Healthy Aging
The EB Supplements Cellular Health Program is designed as a research‑inspired wellness framework, not a medical treatment. By conceptually addressing senescence first, then supporting ongoing cellular maintenance, the program reflects current thinking in cellular aging science while remaining aligned with Health Canada Natural Health Product (NHP) guidelines.
As research into senescence, autophagy, NAD⁺ metabolism, and omega‑3 biology continues to evolve, this two‑phase approach offers a structured, transparent way to integrate emerging science into a proactive healthy aging routine.
Always consult a qualified healthcare professional before making changes to your supplement regimen.
References
- Franceschi, C., Garagnani, P., Parini, P., Giuliani, C., & Santoro, A. (2018). Inflammaging: a new immune–metabolic viewpoint for age-related diseases. Nature Reviews Endocrinology, 14(10), 576–590.
- van Deursen, J. M. (2014). The role of senescent cells in ageing. Nature, 509(7501), 439–446.
- Lopes-Paciencia, S., Saint-Germain, E., Rowell, M. C., Ruiz, A. F., Kalegari, P., & Ferbeyre, G. (2019). The senescence-associated secretory phenotype and its regulation. Cytokine, 117, 15–22.
- Kirkland, J. L., & Tchkonia, T. (2020). Senolytic drugs: from discovery to translation. Journal of Internal Medicine, 288(5), 518–536.
- Yousefzadeh, M. J., Zhu, Y., McGowan, S. J., et al. (2018). Fisetin is a senotherapeutic that extends health and lifespan. EBioMedicine, 36, 18–28.
- Zoico, E., Nori, N., Darra, E., et al. (2021). Senolytic effects of quercetin in an in vitro model of induced senescence. Scientific Reports, 11, 23237.
- Kumar, R., Sharma, A., Kumari, A., Gulati, A., Padwad, Y., & Sharma, R. (2019). Epigallocatechin gallate suppresses premature senescence and induces senescent cell death. Biogerontology, 20(2), 171–189.
- Mizushima, N., & Komatsu, M. (2011). Autophagy: renovation of cells and tissues. Cell, 147(4), 728–741.
- Aman, Y., Schmauck‑Medina, T., Hansen, M., et al. (2021). Autophagy in healthy aging and disease. Nature Aging, 1, 634–650.
- Maiese, K. (2020). Nicotinamide, NAD⁺ metabolism, autophagy and mTOR in aging. Frontiers in Bioscience, 25, 1925–1973.
- Katayoshi, T., Uehata, S., Nakashima, N., et al. (2023). NAD⁺ metabolism and arterial stiffness after long‑term NMN supplementation. Scientific Reports, 13, 2786.
- Fortin, S., PhD. Ex‑vivo study on senolytics and senescent PBMCs. Internal research abstract, EB Supplements.
- Fortin, S., PhD. Second ex‑vivo study on the interaction of omega‑3 (MAG‑O3®) and a senolytic blend. Internal research abstract, EB Supplements.
- Fortin, S., PhD. Reduction of senescent PBMCs following short‑term senolytic supplementation: exploratory case study. Internal research abstract, EB Supplements.
- Fortin, S., PhD. Enhanced senolytic efficacy following omega‑3 index optimisation: exploratory case study. Internal research abstract, EB Supplements.
- Harris, W. S., et al. (2009). Omega‑3 fatty acid blood levels and cardiovascular risk: the Omega‑3 Index. Preventive Medicine, 49(4), 286–291.
- EB Supplements™. MAG‑O3® monoglyceride omega‑3 technology: clinical and preclinical research summary. Product and technical documentation, Canada.
Note: Internal studies and case observations are exploratory and provided for scientific context. They do not constitute definitive clinical evidence.
